Histone deacetylases modulate resistance to the therapy in lung cancer
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The acetylation status of histones located in both oncogenes and tumor suppressor genes modulate cancer hallmarks. In lung cancer, changes in the acetylation status are associated with increased cell proliferation, tumor growth, migration, invasion, and metastasis. Histone deacetylases (HDACs) are a group of enzymes that take part in the elimination of acetyl groups from histones. Thus, HDACs regulate the acetylation status of histones. Although several therapies are available to treat lung cancer, many of these fail because of the development of tumor resistance. One mechanism of tumor resistance is the aberrant expression of HDACs. Specific anti-cancer therapies modulate HDACs expression, resulting in chromatin remodeling and epigenetic modification of the expression of a variety of genes. Thus, HDACs are promising therapeutic targets to improve the response to anti-cancer treatments. Besides, natural compounds such as phytochemicals have potent antioxidant and chemopreventive activities. Some of these compounds modulate the deregulated activity of HDACs (e.g. curcumin, apigenin, EGCG, resveratrol, and quercetin). These phytochemicals have been shown to inhibit some of the cancer hallmarks through HDAC modulation. The present review discusses the epigenetic mechanisms by which HDACs contribute to carcinogenesis and resistance of lung cancer cells to anticancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Curcumin: A Review of Its Effects on Human Health
Hewlings, S., & Kalman, D. (2017) · Foods · doi:10.3390/foods6100092 · Cited by 2,720
Functions and mechanisms of non-histone protein acetylation
Narita, T., Weinert, B. T., & Choudhary, C. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0081-3 · Cited by 1,232 · cited 2×
“HDACs have multiple biological functions in health and disease because they regulate various cellular processes such as cell proliferation, cell cycle, survival, and apoptosis (Kelly and Cowley, 2013; Chen et al., 2015; Narita et al., 2019; Wang P. et al., 2020).”
BackgroundNg, K. P., Hillmer, A. M., Chuah, C. T. H., Juan, W. C., Ko, T. K., Teo, A. S. M., Ariyaratne, P. N., Takahashi, N., Sawada, K., Fei, Y., et al. (2012) · Nature Medicine · doi:10.1038/nm.2713 · Cited by 557
Hu, E., Chen, Z., Fredrickson, T., Zhu, Y., Kirkpatrick, R., Zhang, G.-F., Johanson, K., Sung, C.-M., Liu, R., & Winkler, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908988199 · Cited by 309 · cited 9×
“Treatment with synthetic inhibitors against HDAC-11 suppresses Sox2, reduces cell proliferation and migration, and decreases the CSC subpopulation.”
BackgroundInfluentialKelly, R. D. W., & Cowley, S. M. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130010 · Cited by 297 · cited 1×
“HDACs have multiple biological functions in health and disease because they regulate various cellular processes such as cell proliferation, cell cycle, survival, and apoptosis (Kelly and Cowley, 2013; Chen et al., 2015; Narita et al., 2019; Wang P. et al., 2020).”
BackgroundTong, J. J. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.5.1114 · Cited by 181
Gao, Y., & Tollefsbol, T. O. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082204 · Cited by 90
Schlumm, F., Mauceri, D., Freitag, H. E., & Bading, H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.432773 · Cited by 76
Booth, L., Roberts, J. L., Poklepovic, A., Avogadri-Connors, F., Cutler, R. E., Lalani, A. S., & Dent, P. (2017) · Oncotarget · doi:10.18632/oncotarget.21660 · Cited by 62
Cited by
(2024) · doi:10.7554/elife.87873.3 · Cited by 6
Islam, A., Chang, Y.-C., Chen, X.-C., Weng, C.-W., Chen, C.-Y., Wang, C.-W., Chen, M.-K., Tikhomirov, A. S., Shchekotikhin, A. E., & Chueh, P. J. (2023) · doi:10.1101/2023.03.29.534690
Islam, A., Chang, Y.-C., Chen, X.-C., Weng, C.-W., Chen, C.-Y., Wang, C.-W., Chen, M.-K., Tikhomirov, A. S., Shchekotikhin, A. E., & Chueh, P. J. (2024) · doi:10.7554/elife.87873.2
Metadata
- Authors
- Contreras-Sanzón, E., Prado-Garcia, H., Romero-Garcia, S., Nuñez-Corona, D., Ortiz-Quintero, B., Luna-Rivero, C., Martínez-Cruz, V., & Carlos-Reyes, Á.
- Venue
- Frontiers in Genetics
- Publisher
- Frontiers Media SA
- Published
- 2022-10-03
- Volume
- 13
- Pages
- 960263-960263
- ISSN
- 1664-8021 (ISSN-L)
- OpenAlex
- W4300961020
- Cited by
- 38
- References
- 9
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Histone deacetylases modulate resistance to the therapy in lung cancer. https://app.cochat.ai/papers/10.3389/fgene.2022.960263
- The paper
- Contreras-Sanzón, E., Prado-Garcia, H., Romero-Garcia, S., Nuñez-Corona, D., Ortiz-Quintero, B., Luna-Rivero, C., Martínez-Cruz, V., & Carlos-Reyes, Á. (2022). Histone deacetylases modulate resistance to the therapy in lung cancer. Frontiers in Genetics. https://doi.org/10.3389/fgene.2022.960263
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.